Fusion Antibodies Plc's market cap is currently £7.92M. The company's EPS TTM is p-0.018; its P/E ratio is ―; Fusion Antibodies Plc is scheduled to report earnings on ―, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	£ 1.14M	£ 2.90M	£ 4.80M	£ 4.17M	£ 3.90M
Gross Profit	£ -265.00K	£ 202.00K	£ 1.72M	£ 1.31M	£ 1.15M
Operating Income	£ -2.29M	£ -2.83M	£ -1.33M	£ -1.38M	£ -1.11M
EBITDA	£ -2.06M	£ -2.48M	£ -573.00K	£ -532.00K	£ -431.00K
Net Income	£ -2.23M	£ -2.60M	£ -1.20M	£ -2.90M	£ -697.00K
Balance Sheet
Cash & Short-Term Investments	£ 1.20M	£ 195.00K	£ 2.05M	£ 2.69M	£ 1.54M
Total Assets	£ 2.42M	£ 2.06M	£ 4.92M	£ 5.83M	£ 6.04M
Total Debt	£ 43.00K	£ 75.00K	£ 69.00K	£ 230.00K	£ 380.00K
Net Debt	£ -1.16M	£ -120.00K	£ -1.98M	£ -2.46M	£ -1.16M
Total Liabilities	£ 627.00K	£ 939.00K	£ 1.23M	£ 1.08M	£ 1.23M
Stockholders' Equity	£ 1.79M	£ 1.12M	£ 3.68M	£ 4.75M	£ 4.81M
Cash Flow
Free Cash Flow	£ -1.77M	£ -1.87M	£ -591.00K	£ -1.52M	£ -275.00K
Operating Cash Flow	£ -1.77M	£ -1.75M	£ -333.00K	£ -1.15M	£ -166.00K
Investing Cash Flow	£ 1.00K	£ -114.00K	£ -258.00K	£ -365.00K	£ -109.00K
Financing Cash Flow	£ 2.77M	£ 7.00K	£ -46.00K	£ 2.67M	£ -172.00K

Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History

Income Statement >

Fusion Antibodies Plc Debt to Assets

Balance Sheet >

Fusion Antibodies Plc Cash Flow

Cash Flow >

Fusion Antibodies Plc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing